The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 28, 2017
Filed:
Sep. 08, 2015
Applicant:
Allergan, Inc., Irvine, CA (US);
Inventors:
Haiqing Yuan, Irvine, CA (US);
Richard L. Beard, Newport Beach, CA (US);
Michael E. Garst, Newport Beach, CA (US);
Xiaoxia Liu, Irvine, CA (US);
John E. Donello, Dana Point, CA (US);
Veena Viswanath, Irvine, CA (US);
Assignee:
ALLERGAN, INC., Irvine, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/381 (2006.01); A61K 31/422 (2006.01); A61K 31/404 (2006.01); A61K 31/423 (2006.01); A61K 31/429 (2006.01); A61K 31/4155 (2006.01); A61K 31/4436 (2006.01); A61K 31/4709 (2006.01); A61K 31/428 (2006.01); A61K 31/506 (2006.01); A61K 31/4725 (2006.01); A61K 31/4196 (2006.01); C07C 311/21 (2006.01); C07C 311/44 (2006.01); C07D 231/18 (2006.01); C07D 307/82 (2006.01); C07D 333/34 (2006.01); C07D 405/12 (2006.01); C07D 407/12 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/12 (2006.01); C07D 498/04 (2006.01); C07D 513/04 (2006.01); A61K 31/343 (2006.01); A61K 31/37 (2006.01); A61K 31/4245 (2006.01); A61K 31/427 (2006.01); A61K 31/497 (2006.01); A61K 31/498 (2006.01); A61K 31/5377 (2006.01); A61K 31/538 (2006.01); A61K 31/5383 (2006.01); A61K 31/55 (2006.01); A61K 31/635 (2006.01);
U.S. Cl.
CPC ...
A61K 31/381 (2013.01); A61K 31/343 (2013.01); A61K 31/37 (2013.01); A61K 31/404 (2013.01); A61K 31/4155 (2013.01); A61K 31/4196 (2013.01); A61K 31/422 (2013.01); A61K 31/423 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/429 (2013.01); A61K 31/4245 (2013.01); A61K 31/4436 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/497 (2013.01); A61K 31/498 (2013.01); A61K 31/506 (2013.01); A61K 31/538 (2013.01); A61K 31/5377 (2013.01); A61K 31/5383 (2013.01); A61K 31/55 (2013.01); A61K 31/635 (2013.01); C07C 311/21 (2013.01); C07C 311/44 (2013.01); C07D 231/18 (2013.01); C07D 307/82 (2013.01); C07D 333/34 (2013.01); C07D 405/12 (2013.01); C07D 407/12 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 498/04 (2013.01); C07D 513/04 (2013.01);
Abstract
The present invention relates to novel bis-sulfonamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.